Medicare Enrolled
Dr. Boris Leybel, M.D.
Pain Medicine (Psychiatry & Neurology) Physician · New York, NY
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Leybel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Leybel?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Leybel
Dr. Boris Leybel is a pain medicine physician in New York, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Leybel performed 31,190 Medicare services across 1,124 unique beneficiaries.
Between the years covered by Open Payments, Dr. Leybel received a total of $54,853 from 57 pharmaceutical and/or device companies across 1091 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine (psychiatry & neurology) physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Leybel is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 10% volume in NY
$54,853 industry payments
Medicare Practice Summary
Medicare Utilization ↗31,190
Medicare services
Top 10% in NY for pain medicine (psychiatry & neurology) physician
1,124
Unique beneficiaries
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,560 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
20,100 | $5 | $15 |
| Joint lubricant injection (GenVisc) An injection of hyaluronan or its derivative into a joint space to provide lubrication and cushioning. |
6,675 | $5 | $25 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,117 | $0 | $10 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
619 | $48 | $350 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
414 | $71 | $450 |
| Ultrasound-guided large joint aspiration or injection This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint. |
275 | $101 | $1,389 |
| Limited needle EMG of arm or leg muscles A test that measures the electrical activity in specific muscles of the arm or leg using a needle electrode. This limited study evaluates muscle function in a targeted area. |
184 | $54 | $175 |
| Lidocaine HCl injection for IV infusion, 10 mg Administration of a 10 mg dose of lidocaine hydrochloride via intravenous infusion. |
172 | $0 | $30 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
88 | $95 | $400 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
58 | $173 | $700 |
| Complete ultrasound of brain blood flow An ultrasound test that evaluates blood flow within the brain's blood vessels. It uses sound waves to create images of the vessels and assess circulation. |
55 | $230 | $800 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
54 | $249 | $939 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
54 | $201 | $824 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
52 | $103 | $400 |
| Additional sacral spine nerve root injection with imaging An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging. |
51 | $116 | $905 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
51 | $126 | $1,000 |
| Chemical nerve block for neck muscles Injection of a chemical agent to paralyze specific muscles on the side of the neck, excluding the voice box. |
38 | $177 | $800 |
| Bilateral facial and neck nerve muscle paralysis injection Injection of a chemical agent to paralyze muscles in the face and neck on both sides. |
36 | $135 | $425 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
35 | $137 | $600 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
28 | $327 | $1,260 |
| Trigger point injection, 3 or more muscles Injection of medication into three or more specific muscle trigger points to relieve pain. |
23 | $51 | $190 |
| Ultrasound of brain blood flow An ultrasound test used to examine blood flow within the brain to check for blood clots. |
11 | $140 | $450 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.6% high complexity
95.4% medium
4.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$54,853
Total received (2018-2024)
Avg $7,836/year across 7 years
Top 7% in NY for pain medicine (psychiatry & neurology) physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
57
Companies
1,091
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$41,977 (76.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,876 (23.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$6,373
2023
$6,664
2022
$15,071
2021
$21,131
2020
$3,122
2019
$1,231
2018
$1,262
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$4,094
SCILEX PHARMACEUTICALS INC.
$505
MDD US Operations, LLC
$470
Teva Pharmaceuticals USA, Inc.
$327
PFIZER INC.
$322
Neurocrine Biosciences, Inc.
$136
Kyowa Kirin, Inc.
$112
Amneal Pharmaceuticals LLC
$103
Lilly USA, LLC
$54
Collegium Pharmaceutical, Inc.
$43
Lundbeck LLC
$43
Otsuka America Pharmaceutical, Inc.
$38
Ipsen Biopharmaceuticals, Inc
$36
Eisai Inc.
$34
ARGENX US, INC.
$19
DePuy Synthes Sales Inc.
$18
Abbott Laboratories
$18
Top 3 companies account for 79.5% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$13,414
Biohaven Pharmaceuticals, Inc.
$12,646
Biohaven Pharmaceutical Holding Company Ltd.
$7,620
AbbVie Inc.
$5,612
Allergan, Inc.
$2,725
Teva Pharmaceuticals USA, Inc.
$1,865
Scilex Pharmaceuticals Inc.
$1,011
Horizon Therapeutics plc
$860
PFIZER INC.
$794
Lilly USA, LLC
$701
MDD US Operations, LLC
$574
US WorldMeds, LLC
$541
Neurocrine Biosciences, Inc.
$526
Amgen Inc.
$522
SCILEX PHARMACEUTICALS INC.
$518
Takeda Pharmaceuticals U.S.A., Inc.
$378
UPSHER-SMITH LABORATORIES LLC
$356
Collegium Pharmaceutical, Inc.
$341
DePuy Synthes Sales Inc.
$321
Lundbeck LLC
$278
Avanir Pharmaceuticals, Inc.
$263
Kyowa Kirin, Inc.
$251
ACADIA Pharmaceuticals Inc
$245
Amneal Pharmaceuticals LLC
$238
Almatica Pharma LLC
$230
Novartis Pharmaceuticals Corporation
$211
Flexion Therapeutics, Inc.
$152
Biogen, Inc.
$147
Abbott Laboratories
$137
ARBOR PHARMACEUTICALS, INC.
$132
Upsher-Smith Laboratories LLC
$131
UCB, Inc.
$129
Otsuka America Pharmaceutical, Inc.
$98
Allergan Inc.
$96
Bausch Health US, LLC
$93
SI-BONE, Inc.
$72
Assertio Therapeutics, Inc.
$50
Egalet US Inc
$48
Arbor Pharmaceuticals, Inc.
$43
ASSERTIO THERAPEUTICS, Inc.
$42
Azurity Pharmaceuticals, Inc.
$41
Bioventus LLC
$38
Orthogenrx Inc.
$38
Ipsen Biopharmaceuticals, Inc
$36
Sunovion Pharmaceuticals Inc.
$35
Eisai Inc.
$34
RedHill Biopharma Inc.
$31
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$30
Promius Pharma LLC
$30
Daiichi Sankyo Inc.
$20
ARGENX US, INC.
$19
Horizon Pharma plc
$19
Adamas Pharmaceuticals, Inc.
$19
GE HealthCare
$15
BioDelivery Sciences International, Inc.
$14
Pacira Pharmaceuticals Incorporated
$13
GE HEALTHCARE
$12
Top 3 companies account for 61.4% of all-time payments
Associated products mentioned in payments ›
ADUHELM · AIMOVIG · AJOVY · APLENZIN · APOKYN · APTIOM · AUSTEDO · Aimovig · Apokyn · Austedo XR · BELBUCA · BOTOX · BOTOX COSMETIC · BOTOX THERAPEUTIC · Briviact · COMIRNATY · Cambia · DUEXIS · Durolane · Dysport · EMGALITY · GOCOVRI · GRALISE · GenVisc 850 · Gralise · Horizant · INFINITY · INGREZZA · Infinity DBS Pulse Generators · Iovera · LYRICA · Leqembi · MONOVISC · MYOBLOC · Movantik · NAMZARIC · NAPRELAN · NORTHERA · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · Nourianz · Nuedexta · ONGENTYS · ORTHOVISC · Ongentys · PAXLOVID · PENNSAID · QULIPTA · RAYOS · RELISTOR · REXULTI · REYVOW · RYTARY · SPRIX · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TRINTELLIX · Trintellix · UBRELVY · VIIBRYD · VYEPTI · VYVANSE · VYVGART HYTRULO · Vimpat · XADAGO · XTAMPZA · Xadago · ZAVZPRET · ZEMBRACE SYMTOUCH · ZTLido · Zembrace · Zilretta · iFuse Implant
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (76%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pain medicine (psychiatry & neurology) physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 7% for pain medicine (psychiatry & neurology) physician in NY.
Geographic Context
Pain medicine physicians within 10 mi
15
Per 100K population
0.9
County median income
$104,553
Nearest hospital
NY EYE AND EAR INFIRMARY OF MOUNT SINAI
1.6 mi
1.6 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Leybel is a mixed practice specialist, with above-average Medicare volume (top 10% in NY), with speaking/promotional industry engagement in the top 7% of NY peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Leybel experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Leybel performed 20,100 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Leybel receive payments from pharmaceutical companies?
Yes. Dr. Leybel received a total of $54,853 from 57 companies across 1,091 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Leybel's costs compare to other pain medicine physicians in New York?
Dr. Leybel's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Leybel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Pain Medicine Physicians in New York
Browse pain medicine physicians in New York ranked by procedure volume and transparency data.
Highest volume
Top Pain Medicine Physicians in NY
Pain medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pain Medicine Physicians in NY
Which NY pain medicine physicians receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Biohaven Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Biohaven Pharmaceuticals, Inc.
By company
Biohaven Pharmaceutical Holding Company Ltd. Payments to Doctors
See all physicians who received payments from Biohaven Pharmaceutical Holding Company Ltd.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology